Get the Stockscreener App
281.97
0.76%
+2.14
After Hours:
281.97
Bio-Rad Laboratories Inc. Stock (BIO) Forecast
The Bio-Rad Laboratories Inc. (BIO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $261.46, representing a -7.27% decrease from the current price of $281.97. The highest analyst price target is $277.11, and the lowest is $245.82.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BIO Price Target
Average 325.32
(+15.37% Upside)
Is Bio-Rad Laboratories Inc. (BIO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.24 | Neutral |
| STOCH(9,6) | 36.55 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -12.49 | Buy |
| ADX(14) | 31.59 | Sell |
| William %R | -55.85 | Neutral |
| CCI(14) | 42.75 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
277.71
Buy
|
280.55
Buy
|
| MA20 |
289.24
Sell
|
289.56
Sell
|
| MA50 |
317.25
Sell
|
306.76
Sell
|
| MA100 |
319.03
Sell
|
317.45
Sell
|
| MA200 |
334.03
Sell
|
339.78
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, BIO could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on BIO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.24 indicates that BIO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 36.55 indicates that BIO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that BIO is oversold. This suggests that BIO price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 31.59 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 42.75 indicates that BIO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BIO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bio-Rad Laboratories Inc. financial reports and earnings history, Bio-Rad Laboratories Inc. (BIO) stock could reach $241.09 by 2030, $396.11 by 2040 and $470.66 by 2050. See the projected annual prices until 2050 of the Bio-Rad Laboratories Inc. stock below:
- Bio-Rad Laboratories Inc. (BIO) is expected to reach an average price of $246.91 in 2035, with a high prediction of $250.52 and a low estimate of $197.20. This indicates an $-12.43% rise from the last recorded price of $281.97.
- Bio-Rad Laboratories Inc. (BIO) stock is projected to chart a bullish course in 2040, with an average price target of $352.93, representing an $25.17% surge from its current level. The forecast ranges from a conservative $327.88 to a sky-high $396.11.
- Our analysts predict Bio-Rad Laboratories Inc. (BIO) to jump 5.18% by 2045, soaring from $273.78 to an average price of $296.59, potentially reaching $381.74. While $273.78 is the low estimate, the potential upside is significant.
- Bio-Rad Laboratories Inc. (BIO) stock is expected to climb by 2050, reaching an average of $420.46, a $49.11% jump from its current level. However, a wide range of estimates exists, with high and low targets of $470.66 and $356.36, respectively, highlighting the market's uncertainty.
Bio-Rad Laboratories Inc. Stock (BIO) Year by Year Forecast
Bio-Rad Laboratories Inc. Stock (BIO) Price Forecast for 2024
Our forecast for BIO stock price in 2024 now indicates an average price target of $305.03 with a high forecast of $364.24 and a low forecast of $245.82. The average prediction reflects an increase of +8.18% from the last recorded price of $281.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $275.52 | $245.82 | $277.11 | -2.29% |
| July, 2024 | $281.15 | $268.06 | $288.82 | -0.29% |
| August, 2024 | $297.22 | $271.68 | $309.83 | +5.41% |
| September, 2024 | $308.73 | $286.13 | $311.65 | +9.49% |
| October, 2024 | $308.15 | $283.70 | $312.79 | +9.29% |
| November, 2024 | $316.80 | $292.47 | $323.39 | +12.35% |
| December, 2024 | $339.29 | $313.78 | $340.91 | +20.33% |
Bio-Rad Laboratories Inc. Stock (BIO) Price Forecast for 2025
Bio-Rad Laboratories Inc. Stock (BIO) is expected to reach an average price of $418.78 in 2025, with a high prediction of $563.38 and a low estimate of $274.19. This indicates an +48.52% rise from the last recorded price of $281.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $331.64 | $303.58 | $338.53 | +17.61% |
| February, 2025 | $324.42 | $323.37 | $355.38 | +15.06% |
| March, 2025 | $310.65 | $308.09 | $377.76 | +10.17% |
| April, 2025 | $315.60 | $274.19 | $354.53 | +11.93% |
| May, 2025 | $388.84 | $291.06 | $404.82 | +37.90% |
| June, 2025 | $431.58 | $389.92 | $439.38 | +53.06% |
| July, 2025 | $417.56 | $398.40 | $462.40 | +48.08% |
| August, 2025 | $442.95 | $390.45 | $443.75 | +57.09% |
| September, 2025 | $488.21 | $430.42 | $505.17 | +73.14% |
| October, 2025 | $449.42 | $438.03 | $494.14 | +59.39% |
| November, 2025 | $480.28 | $438.63 | $490.86 | +70.33% |
| December, 2025 | $552.03 | $473.08 | $563.38 | +95.77% |
Bio-Rad Laboratories Inc. Stock (BIO) Price Forecast for 2026
The predicted value for Bio-Rad Laboratories Inc. (BIO) in 2026 is set at an average of $635.64. Estimates vary from a peak of $798.70 to a trough of $472.59, indicating an +125.43% surge from the present price of $281.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $500.44 | $472.59 | $613.73 | +77.48% |
| February, 2026 | $571.29 | $493.69 | $575.02 | +102.61% |
| March, 2026 | $566.64 | $526.44 | $602.44 | +100.96% |
| April, 2026 | $602.39 | $510.51 | $654.54 | +113.64% |
| May, 2026 | $534.54 | $518.44 | $598.38 | +89.57% |
| June, 2026 | $568.24 | $512.85 | $568.52 | +101.52% |
| July, 2026 | $566.49 | $548.24 | $623.50 | +100.90% |
| August, 2026 | $567.33 | $540.78 | $575.77 | +101.20% |
| September, 2026 | $641.04 | $564.12 | $644.14 | +127.34% |
| October, 2026 | $719.03 | $613.67 | $732.17 | +155.00% |
| November, 2026 | $770.00 | $710.32 | $782.76 | +173.08% |
| December, 2026 | $712.00 | $706.46 | $798.70 | +152.51% |
Bio-Rad Laboratories Inc. Stock (BIO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bio-Rad Laboratories Inc. (BIO) is $597.18, with a high forecast of $765.09 and a low forecast of $429.27. This indicates an +111.79% increase from the last price of $281.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $720.04 | $669.76 | $734.98 | +155.36% |
| February, 2027 | $742.79 | $678.36 | $765.09 | +163.43% |
| March, 2027 | $697.70 | $681.21 | $741.05 | +147.44% |
| April, 2027 | $594.52 | $586.16 | $731.66 | +110.85% |
| May, 2027 | $593.04 | $524.83 | $601.45 | +110.32% |
| June, 2027 | $548.96 | $529.39 | $636.98 | +94.69% |
| July, 2027 | $529.71 | $490.62 | $567.03 | +87.86% |
| August, 2027 | $500.82 | $499.60 | $574.04 | +77.62% |
| September, 2027 | $513.85 | $435.43 | $514.98 | +82.24% |
| October, 2027 | $430.15 | $429.27 | $519.39 | +52.55% |
| November, 2027 | $483.27 | $435.12 | $485.71 | +71.39% |
| December, 2027 | $515.53 | $439.18 | $539.49 | +82.83% |
Bio-Rad Laboratories Inc. Stock (BIO) Price Forecast for 2028
In 2028, Bio-Rad Laboratories Inc. (BIO) is projected to reach an average price of $415.43, with a high projection of $519.26 and a low estimate of $311.60. This indicates an +47.33% rise from the last price of $281.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $445.16 | $440.08 | $519.26 | +57.88% |
| February, 2028 | $384.04 | $373.13 | $481.12 | +36.20% |
| March, 2028 | $318.68 | $311.60 | $424.84 | +13.02% |
| April, 2028 | $371.09 | $313.16 | $417.81 | +31.61% |
| May, 2028 | $379.79 | $360.19 | $410.41 | +34.69% |
| June, 2028 | $424.44 | $372.35 | $433.47 | +50.53% |
| July, 2028 | $438.39 | $413.74 | $454.19 | +55.47% |
| August, 2028 | $445.52 | $419.15 | $476.89 | +58.00% |
| September, 2028 | $433.58 | $417.36 | $466.57 | +53.77% |
| October, 2028 | $352.64 | $340.47 | $461.40 | +25.06% |
| November, 2028 | $339.83 | $325.37 | $360.50 | +20.52% |
| December, 2028 | $346.64 | $324.02 | $355.49 | +22.94% |
Bio-Rad Laboratories Inc. Stock (BIO) Price Forecast for 2029
The 2029 price forecast for Bio-Rad Laboratories Inc. Stock (BIO) is $311.38 on average, with a high prediction of $399.37 and a low estimate of $223.40. This represents an +10.43% increase from the previous price of $281.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $372.95 | $336.96 | $399.37 | +32.27% |
| February, 2029 | $349.43 | $343.56 | $386.61 | +23.92% |
| March, 2029 | $343.94 | $318.46 | $374.12 | +21.98% |
| April, 2029 | $312.49 | $307.85 | $345.60 | +10.82% |
| May, 2029 | $271.87 | $229.40 | $322.50 | -3.58% |
| June, 2029 | $274.89 | $264.59 | $282.67 | -2.51% |
| July, 2029 | $290.84 | $260.94 | $294.55 | +3.14% |
| August, 2029 | $288.91 | $270.64 | $306.19 | +2.46% |
| September, 2029 | $306.06 | $280.23 | $332.30 | +8.54% |
| October, 2029 | $318.60 | $290.13 | $328.27 | +12.99% |
| November, 2029 | $247.93 | $237.12 | $318.48 | -12.07% |
| December, 2029 | $238.16 | $223.40 | $262.55 | -15.54% |
Bio-Rad Laboratories Inc. Stock (BIO) Price Forecast for 2030
Bio-Rad Laboratories Inc. Stock (BIO) is expected to reach an average price of $276.23 in 2030, with a high forecast of $342.49 and a low forecast of $209.97. This signifies an -2.03% decrease from the last price of $281.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $227.72 | $209.97 | $241.09 | -19.24% |
| February, 2030 | $238.06 | $225.29 | $248.41 | -15.57% |
| March, 2030 | $263.35 | $235.74 | $267.08 | -6.60% |
| April, 2030 | $265.37 | $241.24 | $274.15 | -5.89% |
| May, 2030 | $261.73 | $250.50 | $277.18 | -7.18% |
| June, 2030 | $275.18 | $248.14 | $278.93 | -2.41% |
| July, 2030 | $292.23 | $256.96 | $295.11 | +3.64% |
| August, 2030 | $301.06 | $268.16 | $305.48 | +6.77% |
| September, 2030 | $312.38 | $293.46 | $320.03 | +10.79% |
| October, 2030 | $331.98 | $288.06 | $334.27 | +17.74% |
| November, 2030 | $265.84 | $249.56 | $342.49 | -5.72% |
| December, 2030 | $292.19 | $238.99 | $297.98 | +3.62% |
0.82%
0.17%
Cap:
|
Volume (24h):